{
    "clinical_study": {
        "@rank": "164807", 
        "acronym": "NIV-NEBU", 
        "arm_group": [
            {
                "arm_group_label": "Solo nebulizer", 
                "arm_group_type": "Experimental", 
                "description": "Amikacin (500 mg/4 mL) administered with an Aerogen AeroNeb Solo nebulizer associated with a bilevel ventilator"
            }, 
            {
                "arm_group_label": "Pro nebulizer", 
                "arm_group_type": "Experimental", 
                "description": "Amikacin (500 mg/4 mL) administered with an Aerogen AeroNeb Pro nebulizer associated with a bilevel ventilator"
            }, 
            {
                "arm_group_label": "NIVO nebulizer", 
                "arm_group_type": "Experimental", 
                "description": "Amikacin (500 mg/4 mL) administered with an Aerogen AeroNeb NIVO nebulizer associated with a bilevel ventilator"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of the study is to compare the pharmacokinetics of nebulized amikacin\n      administered with three vibrating mesh nebulizers coupled with a single limb circuit bilevel\n      ventilator in healthy volunteers. Following our previous in vitro study, our hypotheses are\n      that the pharmacokinetics varies among the devices tested and that a most efficient device\n      can be identified."
        }, 
        "brief_title": "Pharmacokinetics of Nebulized Amikacin in Non Invasive Ventilated Healthy Volunteers.", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Acute Respiratory Insufficiency", 
            "Chronic Respiratory Insufficiency", 
            "Bronchospasm and Obstruction"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Bronchial Spasm", 
                "Respiratory Insufficiency"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  No contraindication of amikacin\n\n          -  Written informed consent\n\n          -  Negative pregnant test (for women)\n\n        Exclusion Criteria:\n\n          -  History of respiratory disease\n\n          -  History of renal disease\n\n          -  History of otological disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 2, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01901497", 
            "org_study_id": "NIVnebu"
        }, 
        "intervention": {
            "arm_group_label": [
                "Solo nebulizer", 
                "Pro nebulizer", 
                "NIVO nebulizer"
            ], 
            "description": "500 mg/4 mL Amikacin nebulized using vibrating mesh nebulizer associated with a single limb bilevel ventilator. The nebulizations are considered as finished when there is no visible evidence of nebulization for a period of 30 seconds.", 
            "intervention_name": "Nebulizer", 
            "intervention_type": "Device", 
            "other_name": "Vibrating-mesh nebulizers"
        }, 
        "intervention_browse": {
            "mesh_term": "Amikacin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "non invasive ventilation", 
            "single limb circuit ventilator", 
            "bilevel", 
            "nebulization", 
            "nebulizer", 
            "vibrating mesh nebulizer", 
            "amikacin"
        ], 
        "lastchanged_date": "February 11, 2014", 
        "location": {
            "contact": {
                "email": "jean-bernard.michotte@hesav.ch", 
                "last_name": "Jean-Bernard Michotte, PhD Student", 
                "phone": "0041213168115"
            }, 
            "contact_backup": {
                "email": "gregory.reychler@uclouvain.be", 
                "last_name": "Gr\u00e9gory Reychler, PhD"
            }, 
            "facility": {
                "address": {
                    "city": "Brussels", 
                    "country": "Belgium", 
                    "zip": "1200"
                }, 
                "name": "Cliniques Universitaires Saint-Luc (Service des soins intensifs)"
            }, 
            "investigator": [
                {
                    "last_name": "Jean-Bernard Michotte, PhD student", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Gr\u00e9gory Reychler, PhD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Belgium"
        }, 
        "number_of_arms": "3", 
        "official_title": "Comparison of Pharmacokinetics of Amikacin Administered by Three Vibrating Mesh Nebulizers in Healthy Volunteers", 
        "overall_contact": {
            "email": "jean-bernard.michotte@hesav.ch", 
            "last_name": "Jean-Bernard Michotte, PhD student"
        }, 
        "overall_contact_backup": {
            "email": "gregory.reychler@uclouvain.be", 
            "last_name": "Gr\u00e9gory Reychler, PhD"
        }, 
        "overall_official": [
            {
                "affiliation": "Cliniques Universitaires Saint-Luc (service de pneumologie), Haute Ecole de Sant\u00e9 Vaud (fili\u00e8re physioth\u00e9rapie), Universit\u00e9 Catholique de Louvain", 
                "last_name": "Jean-Bernard Michotte, PhD student", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Ligue pulmonaire neuch\u00e2teloise", 
                "last_name": "Emilie Jossen, BSc", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Cliniques Universitaires Saint-Luc (service des soins intensifs)", 
                "last_name": "Jean Roeseler, PhD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Universit\u00e9 Catholique de Louvain, Institut de Recherche Exp\u00e9rimentale et Clinique (IREC), P\u00f4le de Pneumologie, ORL & Dermatologie, 1200 Brussels, Belgium", 
                "last_name": "Giuseppe Liistro, MD, PhD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Cliniques Universitaires Saint-Luc (service de pneumologie), Universit\u00e9 Catholique de Louvain", 
                "last_name": "Gr\u00e9gory Reychler, PhD", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Belgium: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The area under the urinary amikacin concentration-time curve after nebulization(AUC0-24 hour) is calculated from the data obtained during 24 hours after nebulization. To determine amikacin absorption during the nebulization, amikacin concentrations are measured in the 24 hours urine collections, which reflected the quantity of dose absorbed via inhalation.", 
            "measure": "Pharmacokinetics of nebulized amikacin", 
            "safety_issue": "No", 
            "time_frame": "within the first 24 hours after nebulization"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01901497"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University Hospital St Luc, Brussels", 
            "investigator_full_name": "Jean-Bernard Michotte", 
            "investigator_title": "MSc, PhD Student", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "University Hospital St Luc, Brussels", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Haute Ecole de Sant\u00e9 Vaud", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Universit\u00e9 Catholique de Louvain", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Ligue pulmonaire neuch\u00e2teloise", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "University Hospital St Luc, Brussels", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}